Iványi, János László <br/><br/>
[Treatment outcome in primary testicular non-Hodgkin lymphoma].  [electronic resource] 

 -  Orvosi hetilap  Oct 2013 
 - 1666-73 p.  digital 
<br/><br/> Publication Type: English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0030-6002 
<br/><br/><label>Standard No.: </label>10.1556/OH.2013.29726  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Burkitt Lymphoma--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Doxorubicin--administration & dosage<br/>Humans<br/>Hungary--epidemiology<br/>Kaplan-Meier Estimate<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Orchiectomy<br/>Prednisone--administration & dosage<br/>Radiotherapy, Adjuvant<br/>Retrospective Studies<br/>Rituximab<br/>Testicular Neoplasms--drug therapy<br/>Treatment Outcome<br/>Vincristine--administration & dosage